Citius Pharmaceuticals Inventory

Citius Pharmaceuticals (CTXR) currently reports a inventory of $23M as of June 2026. That compares with $17M in the prior-year period — up 31.5% year over year. Use the charts on this page to explore Citius Pharmaceuticals's inventory history and peer comparisons.

Citius Pharmaceuticals's inventory increased from $17M to $23M — a 31.5% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Citius Pharmaceuticals reported $23M in inventory as of June 2026. That compares with $17M in the prior-year period — up 31.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current inventory of $23M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Citius Pharmaceuticals, and consider following CTXR for alerts when major investors trade the stock.

Citius Pharmaceuticals is classified in the Healthcare sector. On inventory, it currently shows $23M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CTXR with unrelated industries.